ERBB2 and hypertensive disorder: Trastuzumab is a recombinant humanized monoclonal antibody against the extracellular domain of HER2, while perstuzumab blocks the dimerization of HER2 required for cell activation and proliferation compared to trastuzumab, which can cause hypertension.